Please assess the completion status of the following clinical trial:

Trial Title: A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Advanced medical illness with a life expectancy of 1 to 6 months~2. No clinically significant laxation within 48 hours prior to the first dose of study drug~3. On stable opioid and laxative regimen for a least 3 days prior to treatment~4. Age greater than 18years~5. Females of child-bearing age must have a negative pregnancy test.~Exclusion Criteria:~1. Females who are pregnant or nursing.~2. Previous treatment with MNTX or prior treatment with naltrexone or naloxone for treatment of OIC~3. Any disease process suggestive of gastrointestinal obstruction~4. Fecal ostomy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None
- Arm 3 (Type: PLACEBO_COMPARATOR): None
- Arm 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).